Full Text
Full Text PDF
Abstract
Abstract Cite this article as: Kani HT, Gündüz F. Should we use proton pump inhibitors as an add-on treatment in hereditary hemochromatosis? Turk J Gastroenterol 2018; 29: 254-5.
Most read articles by the same author(s)
- Haluk Tarık Kani, Elif Tufan, Are Cross-Sectional Imaging Modalities Enough for Sarcopenia Assessment? , Turkish Journal of Gastroenterology: Vol. 35 No. 1 (2024): Turkish Journal of Gastroenterology
- Özlen Atuğ, Haluk Tarık Kani, Munkhtsetseg Banzragch, Neşe İmeryüz, Hakan Akın, Incidence rate of anemia in inflammatory bowel diseases , Turkish Journal of Gastroenterology: Vol. 27 No. 2 (2016): Turkish Journal of Gastroenterology
- Haluk Tarık Kani, Covering the Cover , Turkish Journal of Gastroenterology: Vol. 30 No. 8 (2019): Turkish Journal of Gastroenterology
- Feyza Gündüz, Covering the Cover , Turkish Journal of Gastroenterology: Vol. 28 No. 5 (2017): Turkish Journal of Gastroenterology
Article Info
Published In
Journal
Turkish Journal of Gastroenterology
Volume / Issue
Volume 29 · Issue 2
Pages
253-253
History
Published Online
March 15, 2018
Copyright
Copyright (c) 2018 Haluk Tarık Kani, Feyza Gündüz
Affiliations
Haluk Tarık Kani
Department of Internal Medicine, Marmara University School of Medicine, İstanbul, Turkey
Feyza Gündüz
Covering the Cover Editor
Cite this Article
Kani, H. T., & Gündüz, F. (2018). Should we use proton pump inhibitors as an add-on treatment in hereditary hemochromatosis?. Turkish Journal of Gastroenterology, 29(2), 253–253. https://doi.org/10.5152/tjg.2018.17713
Outlines